[1]
M. Donadio, “Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer: Lapatinib e capecitabina in III linea in donna giovane affetta da carcinoma mammario avanzato”, AboutOpen, vol. 4, no. 1, pp. 35–38, Jun. 2018.